KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arbutus Biopharma (ABUS) Interest Coverage Ratio (2017 - 2025)

Arbutus Biopharma's Interest Coverage Ratio history spans 9 years, with the latest figure at 376.48 for Q3 2025.

  • For Q3 2025, Interest Coverage Ratio rose 49.08% year-over-year to 376.48; the TTM value through Sep 2025 reached 429.39, up 22.01%, while the annual FY2024 figure was 557.07, 227.38% down from the prior year.
  • Interest Coverage Ratio for Q3 2025 was 376.48 at Arbutus Biopharma, down from 53.14 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 53.14 in Q2 2025 and bottomed at 917.82 in Q1 2025.
  • The 5-year median for Interest Coverage Ratio is 87.94 (2023), against an average of 259.31.
  • The largest annual shift saw Interest Coverage Ratio crashed 1028.81% in 2023 before it soared 108.37% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 37.14 in 2021, then plummeted by 96.62% to 73.02 in 2022, then plummeted by 545.78% to 471.52 in 2023, then increased by 1.5% to 464.43 in 2024, then rose by 18.94% to 376.48 in 2025.
  • Per Business Quant, the three most recent readings for ABUS's Interest Coverage Ratio are 376.48 (Q3 2025), 53.14 (Q2 2025), and 917.82 (Q1 2025).